tiprankstipranks
Calidi Biotherapeutics (CLDI)
:CLDI
US Market

Calidi Biotherapeutics (CLDI) Financial Statements

Compare
212 Followers

Calidi Biotherapeutics Financial Overview

Calidi Biotherapeutics's market cap is currently $32.65M. The company's EPS TTM is $-5.809; its P/E ratio is ―; Calidi Biotherapeutics is scheduled to report earnings on March 14, 2025, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 45.00K$ 449.00K$ 0.00
Gross Profit$ -1.26M$ -229.00K$ 355.00K$ 0.00
Operating Income$ -28.99M$ -23.13M$ -1.78M$ -6.77M
EBITDA$ -27.58M$ -25.00M$ -9.45M$ -6.65M
Net Income$ -29.22M$ -25.43M$ 3.39M$ -7.94M
Balance Sheet
Cash & Short-Term Investments$ 2.05M$ 472.00K$ 1.06M$ 420.00K
Total Assets$ 10.02M$ 2.60M$ 231.77M$ 1.85M
Total Debt$ 7.24M$ 5.99M$ 5.18M$ 11.72M
Net Debt$ 5.19M$ 5.52M$ 4.12M$ 11.30M
Total Liabilities$ 18.25M$ 43.44M$ 16.45M$ 24.33M
Stockholders' Equity$ -8.23M$ -40.84M$ 215.32M$ -22.48M
Cash Flow
Free Cash Flow$ -27.57M$ -13.64M$ -1.29M$ -5.18M
Operating Cash Flow$ -26.98M$ -13.21M$ -1.08M$ -4.83M
Investing Cash Flow$ -478.00K$ -494.00K$ -230.00M$ -388.00K
Financing Cash Flow$ 29.04M$ 12.09M$ 232.15M$ 4.70M
Currency in USD

Calidi Biotherapeutics Earnings and Revenue History

Calidi Biotherapeutics Debt to Assets

Calidi Biotherapeutics Cash Flow

Calidi Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis